Concepedia

Sabrina Pelliccia

SP

Statistics

Publications

10

Citations

190

H-Index

10

Active since

2011

Affiliations

Azienda Ospedaliera Sant'Andrea(Current)

Sapienza University of Rome

Istituti di Ricovero e Cura a Carattere Scientifico

Azienda Ospedaliera San Giovanni Addolorata

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Sabrina Pelliccia is an author at Azienda Ospedaliera Sant'Andrea specializing in medicine, oncology, and hematology.

Publications per year

2011–2024

10

Publications

10

Tumor-associated and immunochemotherapy-dependent long-term alterations of the peripheral blood NK cell compartment in DLBCL patients

Maria Christina Cox, Simone Battella, Raffaella La Scaleia et al. · OncoImmunology · 2015 · 36 citations · Full text

, , +17

Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone et al. · Journal of Clinical Oncology · 2024 · 28 citations · Full text

, , +16

Use of interim [<sup>18</sup>F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy

Maria Christina Cox, Vincenzo Ambrogi, Valerio Lanni et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 27 citations · Full text

, , +15

The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma

Maria Christina Cox, Sabrina Pelliccia, Luigi Marcheselli et al. · Investigational New Drugs · 2019 · 18 citations

, , +6

The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)

Ombretta Annibali, Stefan Hohaus, Francesco Marchesi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 18 citations

, , +16

1–5 of 10